MapLight Therapeutics, Inc.
NASDAQ:MPLTBiotechnology
+$0.39 today
- Market cap
- $283.41M
- Beta
- 2.65
- P/E (TTM)
- -2.8
- EPS (TTM)
- -$4.41
Volume 0.42M
Average 0.73M
Balance Sheet
Inspect the capital base behind the business.
Assets
$479.51M
FY 2025 · Annual
+250.2% YoYLiabilities
$21.14M
FY 2025 · Annual
-2.7% YoYEquity
$458.37M
FY 2025 · Annual
+297.9% YoYBalance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $55.7M |
| Short-term Investments | $254.4M |
| Other Current | $17.1M |
| Total Current Assets | $327.2M |
| PP&E (Net) | $6.2M |
| Long-term Investments | $85.3M |
| Other Non-current | $36.0K |
| Total Non-current Assets | $91.6M |
| Total Assets | $418.8M |
Analysis
Selected assets total $418.8M for Latest. The largest visible component is Short-term Investments at $254.4M, about 60.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 |
How much cash does MPLT have?
MapLight Therapeutics, Inc. (MPLT) reported $46.73M in cash and equivalents in fiscal 2025.
How much debt does MPLT carry?
MapLight Therapeutics, Inc. (MPLT) reported $5.80M of total debt, with net debt of -$40.93M.
Continue the stock analysis
Jump to another research area for this company.